Similar articles

• The many worlds of reducing interleukin-1.

  Dinarello CA. Dinarello CA. Arthritis Rheum. 2005 Jul;52(7):1960-7. doi: 10.1002/art.21107. Arthritis Rheum. 2005. PMID: 15986340 No abstract available.
• The use of anakinra, an interleukin-1 receptor antagonist, in the treatment of rheumatoid arthritis.

  Cohen SB. Cohen SB. Rheum Dis Clin North Am. 2004 May;30(2):365-80, vii. doi: 10.1016/j.rdc.2004.01.005. Rheum Dis Clin North Am. 2004. PMID: 15172046 Review.
• [Interleukin-1 receptor antagonists in the treatment rheumatoid arthritis].

  Zoń-Giebel A, Kotulska A, Giebel S, Cader SA, Kucharz EJ. Zoń-Giebel A, et al. Przegl Lek. 2002;59(11):916-8. Przegl Lek. 2002. PMID: 12715722 Review. Polish.
• Cytokine blocker licensed for relief of rheumatoid arthritis symptoms.

  [No authors listed] [No authors listed] Am J Health Syst Pharm. 2002 Feb 1;59(3):225-6. doi: 10.1093/ajhp/59.3.225. Am J Health Syst Pharm. 2002. PMID: 11862629 No abstract available.
• [Glucocorticoid-induced osteoporosis in patients with rheumatoid arthritis and collagen diseases].

  Sohen S. Sohen S. Nihon Rinsho. 2004 Feb;62 Suppl 2:673-6. Nihon Rinsho. 2004. PMID: 15035207 Review. Japanese. No abstract available.